Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy

BACKGROUND: Epidemiological evidence suggests that anti-inflammatory and immunomodulatory properties of statins may reduce the risk of infections and infection-related complications. OBJECTIVE: We aimed to assess the impact of prior statin use on coronavirus disease (COVID-19) severity and mortality...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Lipidol
Glavni autori: Mitacchione, Gianfranco, Schiavone, Marco, Curnis, Antonio, Arca, Marcello, Antinori, Spinello, Gasperetti, Alessio, Mascioli, Giosuè, Severino, Paolo, Sabato, Federica, Caracciolo, Maria M., Arabia, Gianmarco, D'Erasmo, Laura, Viecca, Maurizio, Mancone, Massimo, Galli, Massimo, Forleo, Giovanni B.
Format: Artigo
Jezik:Inglês
Izdano: National Lipid Association. 2021
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7833194/
https://ncbi.nlm.nih.gov/pubmed/33390341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacl.2020.12.008
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items